Let’s Get the Nature of Mauritius Back with Japanese Technology - Mauritius Emergency Rescue Project
31.8.2020 07:14:00 EEST | Business Wire | Press release
On July 25, 2020, the Japanese bulk carrier ship WAKASHIO, owned by a subsidiary of Nagashiki Shipping Co., Ltd. of Okayama, Japan, became stranded off the coast of Mauritius, in the Indian Ocean, and about 1,000 tons of heavy oil spilled into the beautiful ocean.
If we do nothing, native sea turtles, classified as an endangered species, would disappear from this world. There are waterfowl habitats of wetlands and mangrove forests designated as wetlands of international importance under the Ramsar Convention, so the ecosystem of these birds could be destroyed. It is said that the coral reefs around Mauritius contain over 40% of the world’s 800 species of hard coral. According to some experts, adhesion of heavy oil makes coral unable to breath, eventually resulting in its death.
If we do not immediately remove the heavy oil spilled from the freighter, the natural environment of Mauritius will be destroyed.
We have thus decided to help remediate the situation by sending the Japan-made adsorption sheets, “MAGIC FIBER,” made specifically to absorb oil, to Mauritius. We cannot get that beautiful ocean cleaned up by ourselves alone, and we need your support to reclaim the unspoiled condition of the Mauritius sea, where turtles, waterfowl, dolphins, and coral once thrived.
Regarding "Magic Fiber", we can cooperate with the transportation to the local site and the local use.
We also look forward to hearing from volunteers.
How You Can Support This Project
Please purchase “MAGIC FIBER” (¥550/unit) from the website of the Mauritius Emergency Rescue Project (http://mauritius-rescue.com/index.html). We will then deliver it directly to the local volunteer organization in Mauritius.
Starting Date: August 21, 2020
Mauritius Emergency Rescue Project
Founders: Mina Kureyama (CEO, Fairy Forest Co., Ltd.)
Nami Sumitani (Representative, Tahitian dance school TAPAIRU)
Supporters:
Water Resources Conservation Council (WRCC)
Media Arts Foundation JAPAN
RIKEN VITAMIN Co., Ltd.
Tokyo Art Co., Ltd.
T-Bridge inc.
Japan Art & Music
Cooperation:
M-TEchX Inc. / Sun Capital Management Corp.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200830005022/en/
Contact information
Mauritius Emergency Rescue Project
Mina Kureyama
contact@mauritius-rescue.com
81-3-66592517
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OXMIQ Raises $35 Million to Scale OxCore™ Architecture1.7.2026 16:15:00 EEST | Press release
OXMIQ Labs Inc., a unified GPU and AI architecture company founded by Raja Koduri, today closed its $35 million Series A financing, bringing the company’s total capital raised to $60 million. The funding will scale OxCore™, OXMIQ’s licensable GPU architecture that allows semiconductor companies and AI system builders to build custom AI silicon without a full chip program. The round was co-led by Fundomo and Samsung Catalyst Fund, with participation from MediaTek, AM Intelligence Labs, Pegatron Venture Capital, CDIB-TEN, Darwin Ventures, and Morgan Creek Digital, among other financial and strategic investors. OXMIQ’s expertise spans the full AI stack, from renewable power and data center infrastructure to silicon IP, electron-to-token machines (ETMs™), along with the software that runs AI factories and agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701241910/en/ OXMIQ Funding raised to date of $60M after current $3
SamanTree Medical’s Histolog ® Scanner Technology Featured in 13 Publications in Special BJU International Issue on Confocal Microscopy in Urology1.7.2026 16:01:00 EEST | Press release
SamanTree Medical, a global leader in surgical imaging innovation, today announced that Histolog Scanner confocal microscopy technology has been featured in 13 peer-reviewed clinical papers in a special issue of BJU International, one of the world’s leading journals in urology. The special edition focuses on a growing body of evidence of the role of confocal microscopy in urologic surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701425845/en/ SamanTree Medical announces that Histolog® Scanner confocal microscopy technology is featured in 13 peer-reviewed clinical papers in a special issue of BJU International. “The special issue represents increasing momentum behind confocal microscopy in urologic surgery,” said Professor Greg Shaw, consultant urologic surgeon at University College London Hospitals (UCLH) and author of several studies in the special issue. “This collection, ranging from radical prostatectomy to eme
Regnology to Acquire Fed Reporter, Accelerating U.S. Leadership and Advancing Regulatory Modernization1.7.2026 16:00:00 EEST | Press release
Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced it has entered into a definitive agreement to acquire Fed Reporter, the market-leading U.S. provider of regulatory reporting solutions for financial institutions of all sizes, including banks, credit unions, and bank holding companies. The acquisition marks a pivotal milestone in Regnology’s U.S. expansion, creating the most comprehensive regulatory reporting coverage across the American financial landscape and extending its reach to more than 4,000 institutions from global banks to community lenders. By combining a proven, cloud-first, agentic-first technology foundation with deeply embedded local expertise, Regnology is uniquely positioned to support more efficient, transparent, and data-driven reporting, while strengthening alignment between financial institutions and supervisory authorities. “This is the next step in our U.S. strategy,” said Rob Mackay, CEO of Regnolog
Xsolla Announces Scholarship Program to Support Emerging Developers1.7.2026 16:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, today announced the launch of the Xsolla Developer Scholarship Program - Cologne 2026 an initiative designed to support independent and mid-tier game developers who face financial barriers to attending gamescom 2026 in Cologne, Germany. As the world’s largest gaming event, gamescom brings together developers, publishers, investors, and industry leaders from across the globe to explore new opportunities, showcase innovative projects, and build meaningful business relationships. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701200418/en/ Graphic: Xsolla The developer scholarship program is designed to help promising studios and independent creators gain access to one of the industry’s most influential events by providing professional development and networking opportunities to accelerate their growth and success. Building on Xsolla’s commitment to supporting game creato
AGC Pharma Chemicals Validates Facilities for CDMO Services via Scientist.com’s VERIF.i ® Program1.7.2026 14:55:00 EEST | Press release
Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform and digital marketplace, and AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) for small molecule API and HPAPI, announced today that AGC has successfully completed an onsite assessment of its new Barcelona facility using the VERIF.i® supplier pre-assessment program. The newly expanded Barcelona site strengthens AGC’s position as a global leader in the development and commercialization of complex small molecule Active Pharmaceutical Ingredients (APIs) and highly potent APIs (HPAPIs). Designed for maximum flexibility, safety, and energy efficiency, the facility expands AGC’s end-to-end capabilities from gram-scale to ton-scale production under the highest quality and sustainability standards. “At AGC Pharma Chemicals, we place the highest priority on the integrity of our operational processes and the expertise of our frontline teams,” said Jun Kurihar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom